The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
The history of clozapine and its emergence in the US market: a review and analysis
Abstract
Clozapine is known as the first `atypical' medication and is effective in people who have treatment-resistant schizophrenia. Its 1990 emergence in the USA was marked by considerable controversy over its high cost, due in large part to having been both the first new antipsychotic medication to come to market in over a decade and the need for comprehensive safety monitor ing within a decentralized health system. This paper traces the histor y of clozapine's discover y and development in Europe, its part in the 1975 Finnish agranulocytosis scare, and its subsequent volatile emergence in the USA. Analyses examine peripheral forces at the time, particularly the influence of political, corporate, medical and societal forces which shaped its market course.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,651
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
The Social Transformation of American Medicine
Leavitt, J. W., & Starr, P. (1984) · The American Historical Review · doi:10.2307/1862729 · Cited by 3,247
A History of Psychiatry: From the Era of the Asylum to the Age of Prozac.
Herman, E., & Shorter, E. (1997) · The Journal of American History · doi:10.2307/2953108 · Cited by 1,056
Clozapine: A Novel Antipsychotic Agent
Oates, J. A., Wood, A. J. J., Baldessarini, R. J., & Frankenburg, F. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241107 · Cited by 687
Termination from Medi-Cal — Does It Affect Health?
Lurie, N., Ward, N. B., Shapiro, M. F., & Brook, R. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408163110735 · Cited by 302
Update on the Clinical Efficacy and Side Effects of Clozapine
Safferman, A., Lieberman, J. A., Kane, J. M., Szymanski, S., & Kinon, B. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.247 · Cited by 301
Povlsen, U. J., Norrng, U., Fog, R., & Gerlach, J. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb01268.x · Cited by 278
CHLORPROMAZINE: New Inhibiting Agent for Psychomotor Excitement and Manic States
LEHMANN, H. E. (1954) · A.M.A. Archives of Neurology & Psychiatry · doi:10.1001/archneurpsyc.1954.02320380093011 · Cited by 251
Cited by
International trends in clozapine use: a study in 17 countries
Bachmann, C. J., Aagaard, L., Bernardo, M., Brandt, L., Cartabia, M., Clavenna, A., Coma Fusté, A., Furu, K., Garuoliené, K., Hoffmann, F., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12742 · Cited by 314
What Do We Know About Neuropsychological Aspects Of Schizophrenia?
Palmer, B. W., Dawes, S. E., & Heaton, R. K. (2009) · Neuropsychology Review · doi:10.1007/s11065-009-9109-y · Cited by 316
Vermeulen, J. M., van Rooijen, G., van de Kerkhof, M. P. J., Sutterland, A. L., Correll, C. U., & de Haan, L. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby052 · Cited by 246
Clozapine: a review of clinical practice guidelines and prescribing trends
Warnez, S., & Alessi-Severini, S. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-102 · Cited by 234
Association between antipsychotic medication use and diabetes
Holt, R. I. G. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1220-8 · Cited by 162
Metadata
- Authors
- Crilly, J.
- Venue
- History of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2007-03
- Volume
- 18
- Issue
- 1
- Pages
- 39-60
- ISSN
- 0957-154X (ISSN-L)
- 1740-2360
- OpenAlex
- W1995063674
- Cited by
- 272
- References
- 28
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The history of clozapine and its emergence in the US market: a review and analysis. https://app.cochat.ai/papers/10.1177/0957154x07070335
- The paper
- Crilly, J. (2007). The history of clozapine and its emergence in the US market: a review and analysis. History of Psychiatry. https://doi.org/10.1177/0957154x07070335
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.